Advertisement

Development of T cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse

Robson G. Dossa, Tanya Cunningham, Daniel Sommermeyer, Indira Medina-Rodriguez, Melinda A. Biernacki, Kimberly Foster and Marie Bleakley

Article Information

PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted July 17, 2017
  • Accepted October 1, 2017
  • Published online October 19, 2017.


Contributors 
  • Robson G. Dossa, 1 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States;
  • Tanya Cunningham, 1 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States;
  • Daniel Sommermeyer, 1 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States;
  • Indira Medina-Rodriguez, 1 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States;
  • Melinda A. Biernacki, 2 Department of Medicine, University of Washington, Seattle, WA, United States;
  • Kimberly Foster, 1 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States;
  • Marie Bleakley, 3 Department of Pediatrics, University of Washington, Seattle, WA, United States

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output